China SXT Pharmaceuticals (SXTC) Accounts Payables (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Accounts Payables of $497648.0 for Q1 2026, down 57.04% year-over-year from $1.2 million in Q1 2025, and down 6.22% quarter-over-quarter from $530662.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Accounts Payables (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Accounts Payables history runs 9 years deep, the most recent figure standing at $497648.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 57.04% year-over-year to $497648.0; the TTM figure through Mar 2026 stood at $497648.0 (down 57.04% YoY), while the FY2026 annual figure was $497648.0, down 57.04% from the prior year.
- Accounts Payables for Q1 2026 stood at $497648.0, down from $530662.0 in the prior quarter.
- The five-year high for Accounts Payables was $3.5 million in Q1 2022, with the low at $497648.0 in Q1 2026.
- The 5-year median for Accounts Payables is $1.3 million (2023), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables increased 26.36% in 2024, then tumbled 68.08% in 2025.
- China SXT Pharmaceuticals' Accounts Payables stood at $1.6 million in 2022, then slipped by 15.72% to $1.3 million in 2023, then rose by 26.36% to $1.7 million in 2024, then sank by 68.08% to $530662.0 in 2025, then decreased by 6.22% to $497648.0 in 2026.
- Business Quant data shows SXTC's Accounts Payables at $497648.0 in Q1 2026, $530662.0 in Q3 2025, and $1.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | China SXT Pharmaceuticals | 32,029.07 | -28.14 Mn | - | 497,648.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 497,648.00 |
| Sep 30, 2025 | 530,662.00 |
| Mar 31, 2025 | 1.16 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Sep 30, 2021 | 1.49 Mn |
| Mar 31, 2021 | 3.05 Mn |
| Sep 30, 2020 | 1.36 Mn |
| Mar 31, 2020 | 1.94 Mn |
| Sep 30, 2019 | 1.96 Mn |
| Mar 31, 2019 | 1.69 Mn |
| Sep 30, 2018 | 2.00 Mn |
| Mar 31, 2018 | 2.41 Mn |